125 related articles for article (PubMed ID: 1996791)
21. The impact of heart failure on the classification of COPD severity.
Güder G; Rutten FH; Brenner S; Angermann CE; Berliner D; Ertl G; Jany B; Lammers JW; Hoes AW; Störk S
J Card Fail; 2012 Aug; 18(8):637-44. PubMed ID: 22858080
[TBL] [Abstract][Full Text] [Related]
22. Effect of tiotropium on lung function decline in early-stage of chronic obstructive pulmonary disease patients: propensity score-matched analysis of real-world data.
Lee HY; Choi SM; Lee J; Park YS; Lee CH; Kim DK; Lee SM; Yoon HI; Yim JJ; Kim YW; Han SK; Yoo CG
Int J Chron Obstruct Pulmon Dis; 2015; 10():2185-92. PubMed ID: 26508848
[TBL] [Abstract][Full Text] [Related]
23. Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department: a randomized controlled trial.
Rowe BH; Bota GW; Fabris L; Therrien SA; Milner RA; Jacono J
JAMA; 1999 Jun; 281(22):2119-26. PubMed ID: 10367823
[TBL] [Abstract][Full Text] [Related]
24. Bronchodilator response of advanced lung function parameters depending on COPD severity.
Jarenbäck L; Eriksson G; Peterson S; Ankerst J; Bjermer L; Tufvesson E
Int J Chron Obstruct Pulmon Dis; 2016; 11():2939-2950. PubMed ID: 27932874
[TBL] [Abstract][Full Text] [Related]
25. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study.
Dompeling E; van Schayck CP; van Grunsven PM; van Herwaarden CL; Akkermans R; Molema J; Folgering H; van Weel C
Ann Intern Med; 1993 May; 118(10):770-8. PubMed ID: 8470851
[TBL] [Abstract][Full Text] [Related]
26. A multicenter study of nebulized bronchodilator solutions in chronic obstructive pulmonary disease.
Friedman M
Am J Med; 1996 Jan; 100(1A):30S-39S. PubMed ID: 8610715
[TBL] [Abstract][Full Text] [Related]
27. Acute bronchodilator trials in chronic obstructive pulmonary disease.
Nisar M; Earis JE; Pearson MG; Calverley PM
Am Rev Respir Dis; 1992 Sep; 146(3):555-9. PubMed ID: 1387772
[TBL] [Abstract][Full Text] [Related]
28. Repeated dyspnea score and percent FEV1 are modest predictors of hospitalization/relapse in patients with acute asthma exacerbation.
Schneider JE; Lewis LM; Ferguson I; House SL; Liu J; Matsuda K; Johnson K
Respir Med; 2014 Sep; 108(9):1284-91. PubMed ID: 25087835
[TBL] [Abstract][Full Text] [Related]
29. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
[TBL] [Abstract][Full Text] [Related]
30. Randomized trial of the use of heliox as a driving gas for updraft nebulization of bronchodilators in the emergent treatment of acute exacerbations of chronic obstructive pulmonary disease.
deBoisblanc BP; DeBleiux P; Resweber S; Fusco EE; Summer WR
Crit Care Med; 2000 Sep; 28(9):3177-80. PubMed ID: 11008978
[TBL] [Abstract][Full Text] [Related]
31. Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease.
Pisi R; Aiello M; Zanini A; Tzani P; Paleari D; Marangio E; Spanevello A; Nicolini G; Chetta A
Int J Chron Obstruct Pulmon Dis; 2015; 10():1191-7. PubMed ID: 26150710
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of chronic bronchitis and chronic pulmonary obstructive disease in primary care].
Miravitlles M; Murio C; Guerrero T; Segú JL
Arch Bronconeumol; 1999 Apr; 35(4):173-8. PubMed ID: 10330538
[TBL] [Abstract][Full Text] [Related]
33. Bronchodilator responsiveness in patients with chronic heart failure.
Minasian AG; van den Elshout FJ; Dekhuijzen PN; Vos PJ; Willems FF; van den Bergh PJ; Heijdra YF
Heart Lung; 2013; 42(3):208-14. PubMed ID: 23273658
[TBL] [Abstract][Full Text] [Related]
34. Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations.
Calverley PM; Postma DS; Anzueto AR; Make BJ; Eriksson G; Peterson S; Jenkins CR
Int J Chron Obstruct Pulmon Dis; 2016; 11():381-90. PubMed ID: 26952309
[TBL] [Abstract][Full Text] [Related]
35. [Immediate bronchodilator response to formoterol in poorly reversible chronic obstructive pulmonary disease].
Rubin AS; Souza FJ; Hetzel JL; Moreira Jda S
J Bras Pneumol; 2008 Jun; 34(6):373-9. PubMed ID: 18622504
[TBL] [Abstract][Full Text] [Related]
36. Nebulized bronchodilators for outpatient management of stable chronic obstructive pulmonary disease.
Colice GL
Am J Med; 1996 Jan; 100(1A):11S-18S. PubMed ID: 8610712
[TBL] [Abstract][Full Text] [Related]
37. Intravenous aminophylline in the treatment of acute bronchospastic exacerbations of chronic obstructive pulmonary disease.
Seidenfeld JJ; Jones WN; Moss RE; Tremper J
Ann Emerg Med; 1984 Apr; 13(4):248-52. PubMed ID: 6367554
[TBL] [Abstract][Full Text] [Related]
38. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial.
Bölükbas S; Eberlein M; Eckhoff J; Schirren J
Eur J Cardiothorac Surg; 2011 Jun; 39(6):995-1000. PubMed ID: 20970351
[TBL] [Abstract][Full Text] [Related]
39. [A three years longitudinal follow-up study of pulmonary function changes in patients with chronic obstructive pulmonary disease].
Wang J; Zhou XM; Yang X; Zhao ST; Ma QL; Wang CZ
Zhonghua Nei Ke Za Zhi; 2016 Apr; 55(4):302-6. PubMed ID: 27030620
[TBL] [Abstract][Full Text] [Related]
40. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.
Anthonisen NR; Connett JE; Kiley JP; Altose MD; Bailey WC; Buist AS; Conway WA; Enright PL; Kanner RE; O'Hara P
JAMA; 1994 Nov; 272(19):1497-505. PubMed ID: 7966841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
